Fungal metabolites as pharmaceuticals

Andrew M. Beekman, Russell A. Barrow

    Research output: Contribution to journalArticlepeer-review

    47 Citations (Scopus)

    Abstract

    Natural products, their derivatives or compounds based on natural product leads constitute ~50 % of clinically used pharmaceuticals. This review highlights pharmaceuticals currently used in Australia and New Zealand that have their origins in fungal metabolites, discussing the natural products chemistry and medicinal chemistry leading to their application as pharmaceuticals.
    Original languageEnglish
    Pages (from-to)827-843
    Number of pages17
    JournalAustralian Journal of Chemistry
    Volume67
    Issue number6
    DOIs
    Publication statusPublished - 19 May 2014

    Cite this